Answers are grounded in this paper and cite their sources.
We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.
No takes yet. Share an insight, caveat, or question.
Demirtunç et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: